The HealthTech Activator (HTA) is a coordinated, ecosystem-wide support mechanism for early-stage founders and companies in NZ’s healthtech sector.
The HTA makes it easier for healthtech companies to find and access the support they need to turn their health innovations into successful businesses. In doing so, it aims to advance, de-risk and accelerate the commercialisation of innovation in NZ’s healthtech ecosystem.
The HealthTech Activator directory is provided to connect members of the healthtech sector to service providers, funding organisations, and networks to support their commercialisation journey.
The latest in NZ healthtech: registration is open for June's online HTA events - covering reimbursement, regulatory, and market validation - and HealthTech Week 2023.
The latest in NZ healthtech: registration is open for June's online HTA events - covering reimbursement, regulatory, and market validation - and HealthTech Week 2023.
The latest in NZ healthtech, including an article from Angel Association of NZ, upcoming HTA and community events, and the sector news from the past month.
The latest in NZ healthtech, including an article from Angel Association of NZ, upcoming HTA and community events, and the sector news from the past month.
Suse Reynolds, Executive Chair of Angel Association of New Zealand (AANZ), discusses the role of angel investment, AANZ as a resource for all stakeholders, and some thoughts on the current investment climate.
Suse Reynolds, Executive Chair of Angel Association of New Zealand (AANZ), discusses the role of angel investment, AANZ as a resource for all stakeholders, and some thoughts on the current investment climate.
This online workshop is for device companies that have an interest in US reimbursement processes and learning about the key considerations for developing a reimbursement strategy.
This online workshop is for device companies that have an interest in US reimbursement processes and learning about the key considerations for developing a reimbursement strategy.
This webinar will provide participants with an overview of ins and outs of FDA engagement for medical device companies and include a discussion of significant FDA initiatives, closing with a Q&A.
This webinar will provide participants with an overview of ins and outs of FDA engagement for medical device companies and include a discussion of significant FDA initiatives, closing with a Q&A.
This market validation workshop is aimed at early stage healthtech companies, or healthtech companies that would like to have a fresh look at their market and how they have validated it to date.
This market validation workshop is aimed at early stage healthtech companies, or healthtech companies that would like to have a fresh look at their market and how they have validated it to date.